1-3 of 3
Guolin Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Data of a Single-Arm, Phase II Study of Orelabrutinib with/without Rituximab in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma after BTK Inhibitor Therapy

Free
Linlin Cao, Song Hao, Cuicui Wang, Qiang Xu, Chenyang Zhou, Maogui Hu, Jing Ming, Guolin Wu, Dandan Fan, Yuanyuan Feng, Xinchen Wang, Hailiang Chu, Kaiyang Ding
Journal: Blood
Blood (2024) 144 (Supplement 1): 3240.
https://doi.org/10.1182/blood-2024-198491
Published: 2024
Journal Articles

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Free
Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Kaiyang Ding, Bingzong Li, MD PhD, Bing Chen, Zhengzheng Fu, Sili Wang, Wenhao Zhang, MD PhD, Xin Zhou, Luoming Hua, PhD, Wei Yang, Luo Jun, Liang Wang, Tianhong Xu, Yang Yang, Weida Wang, MD, Guolin Wu, Yun Huang, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5592.
https://doi.org/10.1182/blood-2019-130040
Published: 2019
Journal Articles

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

Free
Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Sili Wang, Xin Zhou, Kaiyang Ding, Wenhao Zhang, MD PhD, Wei Yang, Bingzong Li, MD PhD, Zhengzheng Fu, Bing Chen, Luoming Hua, PhD, Liang Wang, Luo Jun, Yang Yang, Tianhong Xu, Weida Wang, MD, Yun Huang, Guolin Wu, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3181.
https://doi.org/10.1182/blood-2019-128614
Published: 2019